Knight Therapeutics, Inc. (GUD.TO)
6.00
-0.04
(-0.66%)
CAD |
TSX |
Dec 19, 16:00
Knight Therapeutics EPS Diluted (Quarterly): -0.038 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Profound Medical Corp. | -0.365 |
| Biocure Technology, Inc. | -0.0029 |
| Core One Labs, Inc. | -- |
| Restart Life Sciences Corp. | -0.0059 |
| NanoSphere Health Sciences, Inc. | -0.0013 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.791M |
| Revenue (Quarterly) | 121.55M |
| Total Expenses (Quarterly) | 125.34M |
| Enterprise Value | 606.42M |
| Gross Profit Margin (Quarterly) | 33.21% |
| Profit Margin (Quarterly) | -3.12% |
| Earnings Yield | -0.59% |
| Normalized Earnings Yield | -0.245 |